+1 (941) 951-0126
  • Skip to content
    • About Us
      • Leadership Team
      • Scientific Advisors
      • Board of Directors
      • Partnerships, Collaborations and Joint Development Agreements
    • A New Paradigm
      • Human Microbiome
      • Drug Discovery
      • MiNE™ Platform
      • Qi601™ Research
    • Intellectual Property
    • Pipeline
      • Product Pipeline
      • Partnerships
    • News
      • In the News
      • Press Releases
    • Microplastics Forum and Research
    • Careers
    • Contact
    Nicholas T. Monsul, M.D., F.A.C.S.
    Co-Founder and Chairman
    Nicholas T. Monsul, MD
    Eva A. Berkes, M.D.
    Co-Founder and Chief Scientific Officer
    Eva Berkes, MD
    Larry Weiss, MD
    Scientific Advisor
    Larry Weiss
    Julia Durack MD
    Scientific Advisor
    Julia Durack
    David Salinwanchik, JD
    Patent Attorney Advisor
    David Salinwanchik, JD
    Miriam Guggenheim
    Regulatory Advisor
    Miriam Guggenheim
    Bill Gale
    Direct Marketing Advisor
    Bill Gale
    Daniel Fredeen
    Direct Marketing/Ops Advisor
    Daniel Fredeen
    Mike Esson
    Creative Advisor
    Mike Esson
    Ian Longen
    Video/Social Media Advisor
    Ian Longen

    Quorum Innovations

    2068 Hawthorne Street
    Sarasota, FL 34239
    Mon - Fri | 8:30-5:00
    +1 (941) 951-0126

    About Us

    Quorum Innovations is a specialty biopharmaceutical company focused on discovering, developing and delivering innovative biotherapeutics to physicians and their patients. Developing therapeutics based on a unique understanding of the role the human microbiome plays in health and disease, Quorum is poised to become a leader in the emerging field of microbiome therapeutics.

    Navigation

    • Home
    • About Us
    • A New Paradigm
    • Pipeline
    • News
    • Careers
    • Contact

    Newsletter

  • © 2025 Quorum Innovations, All Rights Reserved.